Table 2:

Concordance among tumor response assessment performed 2–6 weeks after completion of radiotherapy with both EPMR and PRMR as baseline examsa

PRMR as BaselineEPMR as Baseline
True ProgressionbPseudoprogressionbStable DiseasePartial ResponseTotal
True Progressionb90009
Pseudoprogressionb03003
Stable Disease038112
Partial Response01124
Total979328

  • ↵a Patients: n = 28.

  • ↵b Discrimination between true progression and pseudoprogression in patients showing progressive disease was performed by evaluating an MR exam performed more than 3 months after radiotherapy.